BUY Marksans Pharma Limited — VLA Ambala
byVLA AmbalaHorizon: 1–3 months11 Jun 2026via NDTV Profit (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active short-term BUY call on this stock
Advisor consensus · same horizon·11 Jun · 2mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Marksans Pharma
- BUY — IDBI Capital29 Sept 2026 · ~3 months · target ₹380 · SL hit
- BUY — Vishnu Kant Upadhyay, Master Capital Services29 Sept 2026 · ~2 weeks · target ₹380 · SL hit
- BUY — Rajesh Satpute29 Sept 2026 · ~2 weeks · target ₹360 · SL hit
- BUY — Kunal Saraogi24 Sept 2026 · Same day · target ₹356 · SL hit
- BUY — Vinay Rajani, HDFC Securities24 Sept 2026 · ~2 weeks · target ₹370 · SL hit
More from VLA Ambala
- BUY Surya Roshni29 Oct 2026 · ~2 weeks · target ₹245 · Active
- BUY R R Kabel29 Oct 2026 · ~2 weeks · target ₹2,300 · SL hit
- BUY Aptus Value Housing Finance India29 Oct 2026 · ~2 weeks · target ₹230 · Active
- BUY HBL Engineering29 Oct 2026 · ~2 weeks · target ₹880 · Active
- BUY Ajmera Realty & Infra India29 Oct 2026 · ~2 weeks · target ₹144 · Active

